Focus: 71st AACC Annual Scientific Meeting & Clinical Lab Expo

• share
• favorite_border

The Association for Diagnostics and Laboratory Medicine (ADLM), formerly AACC, welcomed thousands of laboratory experts to the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo from July 23-27. At this year’s special meeting celebrating ADLM’s 75th anniversary, the organization officially rolled out a new name that reflects the association’s role as advocate and champion for a larger community specializing in diagnostics and laboratory medicine, as well as its global reach.

• share
• favorite_border

Two studies featured today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo highlight advances that could boost the accuracy of marijuana tests and provide vital information for addressing the opioid epidemic.

• share
• favorite_border

Shenzhen Superbio Technology Co., LTD. (Superbio) has received clearance from the US Food and Drug Administration (FDA) on the first ever point-of-care instrument intended for qualitative detection of fentanyl in human urine and has fully released authorization to Bioeasy USA, Inc.(Bioeasy) of this product in the United States of America.

• share
• favorite_border

PBD Biotech developers of Actiphage TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured the grant of a US patent for its diagnostic kit. The company is exhibiting in the AACC Clinical Lab Expo on booth #4578.

• share
• favorite_border

Today, at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, scientists will present new data about rates of co-infections with SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) in the United States.

• share
• favorite_border

Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs), according to research presented today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo.

• share
• favorite_border

A new artificial intelligence model can predict people’s risk of multiple sclerosis years before diagnosis, potentially enabling quicker treatment, according to research revealed today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo.

• share
• favorite_border

The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce the recipients of its 2023 Top Corporate Supporter Award.

• share
• favorite_border

Taiwanese IVD (In-Vitro Diagnostic) manufacturer General Biologicals Corporation (GBC) today unveiled two CellBio™ circulating tumor cell (CTC) cancer detection products at the American Association for Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo, being held July 23-27 in Anaheim, California.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a name change to the Association for Diagnostics & Laboratory Medicine.

• share
• favorite_border

At the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory experts will present cutting-edge research and technology that is shaping the future of clinical testing and patient care.

• share
• favorite_border

During the AACC - Annual Scientific Meeting & Clinical Lab Expo, held in Anaheim, California (USA) from July 23rd to 27th, the Brazilian health tech company Hilab, specializing in clinical analysis tests, participated in the congress alongside ABIMO - Brazilian Association of Medical Devices Industry.

• share
• favorite_border

During the AACC - Annual Scientific Meeting & Clinical Lab Expo, held in Anaheim, California (USA) from July 23rd to 27th, the Brazilian health tech company Hilab, specializing in clinical analysis tests, participated in the congress alongside ABIMO - Brazilian Association of Medical Devices Industry.

• share
• favorite_border

Today, AACC—in collaboration with the American Diabetes Association (ADA)—released evidence-based guidelines to help diagnose and manage patients with diabetes using the latest laboratory-analysis tools. The guidelines replace previous versions published in 2002 and 2011. The new document features extensive updates on continuous glucose monitoring and more precise recommendations for measuring glucose and hemoglobin A1c, a marker of average blood glucose. Written by a cross-disciplinary team of medical experts, the guidelines provide specific, actionable advice that will enhance collaboration among healthcare professionals and improve care for millions of people.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the journal Clinical Chemistry received an impact factor of 9.3 —the second highest in the journal’s history—and the Journal of Applied Laboratory Medicine (JALM) received its first impact factor, of 2.0, according to the newly released 2022 Clarivate Journal Citation Reports.

• share
• favorite_border

Today, AACC—in collaboration with the National Kidney Foundation (NKF)—released guidance to reduce racial and gender disparities in the care of patients with chronic kidney disease (CKD). The document gives members of the healthcare team actionable, evidence-based tools to improve equity in kidney health, including recommendations for using an updated algorithm that does not disproportionately affect any one group of individuals.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Anthony A. Killeen, MB, BCh, PhD, MSc, has been elected to serve on the AACC board of directors as president-elect starting in August 2023. Following this, he will serve successive terms as the association’s president from August 2024-July 2025 and as past president from August 2025-July 2026. In addition, the AACC membership elected a new secretary and two new directors to the association’s board. They will take office in August 2023 along with the incoming president of AACC Academy and the incoming chair of the AACC Clinical Laboratory Scientists Council, both of whom will also serve on the board.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2023 AACC and AACC Academy Awards. Through this annual awards program, AACC strives to support laboratory medicine professionals in all stages of their careers and to build awareness of the essential role that clinical laboratory testing plays in improving patient health.

• share
• favorite_border

AACC has issued expert guidance on clinical testing for procalcitonin, a blood marker that helps detect serious bacterial infections and sepsis. By giving clinicians and laboratory professionals much-needed clarity on how to best use procalcitonin tests, the new guidelines could improve the treatment of critically ill patients and those with certain lower respiratory infections.

• share
• favorite_border

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that MaryAnne Elma has assumed the position of chief science and policy officer for the association, effective today.

• share
• favorite_border

A first-of-its-kind study has established pediatric reference intervals for two common tests for cardiovascular disease. Published in AACC’s The Journal of Applied Laboratory Medicine, these findings are crucial to advancing diagnosis and treatment of heart conditions in children.

• share
• favorite_border

Scientists have developed a test that could greatly improve quality of life for infants with homocystinuria (HCU)—a congenital disease that, if not treated early, causes serious complications. Research demonstrating the efficacy of this test was published today in AACC’s Clinical Chemistry journal.

• share
• favorite_border

A little known but major challenge facing modern medicine is a lack of interoperability—i.e., the ability to effectively share clinical data, and especially clinical test results, between different healthcare organizations. In an effort to solve this issue, AACC has released a position statement today that urges HHS to fund interoperability pilot programs and to incentivize its adoption, which would vastly improve the quality of care patients receive.

• share
• favorite_border

With the goal of improving cervical cancer care, AACC has published a new guidance document with expert recommendations on detecting this cancer. The guidance aims to update healthcare and laboratory medicine professionals on the latest advancements in this field, and to help them select the most effective cervical cancer detection strategy for their patients.

• share
• favorite_border

In this special Data Science Issue, AACC’s The Journal of Applied Laboratory Medicine highlights the groundbreaking work that laboratory medicine experts are doing to advance patient care through data analytics and to make this game-changing technology a routine part of healthcare.

• share
• favorite_border

Breaking research demonstrates the efficacy of two data analytics-based strategies that clinical labs employed to meet COVID-19 testing demands during the height of the pandemic. These findings, published in the Data Science Issue of AACC’s The Journal of Applied Laboratory Medicine, give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.

• share
• favorite_border

AACC applauds the decision of the United States Congress to exclude the Verifying Accurate Leading-edge IVCT Development (VALID) Act from its end of year omnibus bill.

• share
• favorite_border

A first-of-its-kind study published today in AACC’s Clinical Chemistry journal shows that a novel drug test detects a new class of synthetic cannabinoids called OXIZIDs. This test could enable drug enforcement agencies to identify OXIZID users and could play a critical role in efforts to stop the spread of these drugs.

• share
• favorite_border

AACC has issued a new guidance document with expert recommendations for performing point-of-care tests for fertility and reproductive health. As the use of point-of-care testing rises in these fields, this guidance is intended to ensure that patients and their babies fully benefit from it.

• share
• favorite_border

AACC welcomed thousands of medical professionals and healthcare leaders to the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo from July 24-28. The meeting featured groundbreaking diagnostic advances that will solve challenging patient health problems, and affirmed just how essential laboratory medicine professionals are to patient safety and care.

• share
• favorite_border

The 2023 EuroMedLab Congress will feature innovative and diverse education opportunities, including lectures, symposia, recent advancements in clinical practice and science, poster presentations, and industry exhibits, as well as an excellent social program

• share
• favorite_border

In 70 years, Laboratory Medicine underwent many changes, incorporating the concept of P6 medicine (Personalised, Predictive, Preventive, Participatory, Psychocognitive, Public), a model of highly participatory, interactive,“augmented” lab med to better interact with health professionals and patients

• share
• favorite_border

Faster mobile PCR test device helping business continuity

• share
• favorite_border

Taiwan Excellence Pavilion is honored to have Chroma ATE Inc., Taiwan Advanced Nanotech, CYP (Cypress Technology), :dc (Dacian Technology), and IDRC (CHYNG HONG ELECTRONIC CO. LTD.) representing Taiwan to showcase their phenomenal innovations starting on the 26th of this month. It is estimated to attract over 20 thousand visiting practitioners from affiliated fields to attend and proceed with further discussions in business over the 3-day AACC expo.

• share
• favorite_border

DIFF-Line™ by CellaVision is a new, comprehensive solution for small labs. It consists of three instruments for smearing, staining, and analyzing peripheral blood smears: CellaVision® DC-1, RAL® SmearBox, and RAL® StainBox.

• share
• favorite_border

Vircell, leading provider of independent external run controls for nucleic acid testing, announces the launch of a new independent molecular control which will help laboratories all over the world to combat the current outbreak

• share
• favorite_border

The Call For Study Proposals Strategic Objectives are: 1) To promote directed research evaluating the role of lab medicine on clinical outcomes 2) To build awareness and understanding on the critical role of lab medicine plays in healthcare outcomes. Terms and conditions for the Grant are described.